18F-FDG PET/CT对肾细胞癌肉瘤样分化的诊断与预后价值
本回顾性研究评估18F-FDG PET/CT预测肾细胞癌肉瘤样分化及其预后的价值。SDRCC的SUVmax、MTV、TLG、SUVmean显著高于non-SDRCC(P<0.05);HG-SDRCC的SUVmax、TLG、SUVmean显著高于non-HG-SDRCC(P<0.05)。TLG>500为DFS不良的危险因素,SUVmax>11和SUVmean>5.2为OS不良的危险因素。
要点
- SDRCC的SUVmax、MTV、TLG、SUVmean显著高于non-SDRCC(P<0.05)。
- HG-SDRCC的SUVmax、TLG、SUVmean显著高于non-HG-SDRCC(P<0.05)。
- TLG>500为DFS不良危险因素,SUVmax>11和SUVmean>5.2为OS不良危险因素。
核心结论
- 18F-FDG PET/CT可有效区分侵袭性更高的HG-SDRCC。
- 本研究所建预后模型显示,代谢参数(TLG对DFS、SUVmax/SUVmean对OS)比肉瘤样分化程度是更稳健的患者结局预测因子。
研究设计与样本
- 回顾性研究,纳入新诊断并使用18F-FDG PET/CT分期的肉瘤样分化肾细胞癌(SDRCC)患者。
- 患者分为高级别肉瘤样分化RCC(HG-SDRCC)、低级别肉瘤样分化RCC(LG-SDRCC)和非肉瘤样分化RCC(non-SDRCC)。
主要发现
- SDRCC的SUVmax、MTV、TLG、SUVmean值显著高于non-SDRCC(P<0.05)。
- HG-SDRCC的SUVmax、TLG、SUVmean值显著高于non-HG-SDRCC(P<0.05)。
- ROC曲线显示SUVmax和SUVmean可有效区分HG-SDRCC与non-HG-SDRCC。
- log-rank检验识别SUVmax>11、MTV>95、TLG>500、SUVmean>5.2、侵犯周围组织和/或器官及转移为SDRCC患者的危险因素。
- 多因素Cox比例风险模型分析表明TLG>500为DFS不良的危险因素,SUVmax>11和SUVmean>5.2为OS不良的危险因素。
关键数值与推荐
- SUVmax>11、MTV>95、TLG>500、SUVmean>5.2、侵犯周围组织和/或器官及转移为SDRCC患者的危险因素(log-rank检验)。
- TLG>500为DFS不良的危险因素(多因素Cox分析)。
- SUVmax>11和SUVmean>5.2为OS不良的危险因素(多因素Cox分析)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sarcomatoid differentiation is an invasive dedifferentiated feature of tumor and associated with poor prognosis in renal cell carcinoma (RCC) patients. This study aimed to evaluate the utility of 18F-FDG PET/CT in predicting sarcomatoid differentiation in RCC and its potential prognostic value. RESULTS: This retrospective study assessed newly diagnosed sarcomatoid differentiation renal cell carcinoma (SDRCC) patients who were staged using 18F-FDG PET/CT. Patients were categorized into high-grade sarcomatoid differentiation RCC (HG-SDRCC), low-grade sarcomatoid differentiation RCC (LG-SDRCC), and non-sarcomatoid differentiation RCC (non-SDRCC). The maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were compared. Overall survival (OS) and disease-free survival (DFS) were analyzed. SUVmax, MTV, TLG, and SUVmean values were significantly higher in SDRCC compared to non-SDRCC (P < 0.05). Additionally, SUVmax, TLG, and SUVmean were significantly higher in HG-SDRCC compared to non-HG-SDRCC (P < 0.05). ROC curves revealed that SUVmax and SUVmean were effective for distinguishing HG-SDRCC from non-HG-SDRCC. The log-rank test identified SUVmax > 11, MTV > 95, TLG > 500, SUVmean > 5.2, invasion of peripheral tissue and/or organs, and metastasis as risk factors for SDRCC patients. Multivariate Cox proportional hazards model analyses indicated that TLG > 500 was a risk factor for poor DFS, while SUVmax > 11 and SUVmean > 5.2 were risk factors for poor OS. CONCLUSIONS: 18F-FDG PET/CT can effectively differentiate HG-SDRCC with more aggressive malignancy. The prognostic model developed in this study demonstrates that metabolic parameters, particularly TLG for DFS and SUVmax/SUVmean for OS, serve as more robust predictors of patient outcomes than the degree of sarcomatoid differentiation.
引用
- Na R, Chen Z, Liu Y, et al. Diagnostic and prognostic role of 18F-FDG PET/CT for sarcomatoid differentiation in renal cell carcinoma. EJNMMI Res. 2025. PMID: 39971809. doi:10.1186/s13550-025-01206-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。